Therapeutic inertia has been implicated as a significant contributory factor in suboptimal diabetes management. This course uses a Q&A format to explore the phenomenon, with particular focus on primary care.
From obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
Transplants of insulin-producing islets offer the hope of glucose regulation without daily insulin injections. This course looks at advances in this exciting field of diabetes treatment and the challenges still to come.
This course introduces you to the current unmet need in type 1 diabetes and explores trial data in the use of adjunct therapies including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.